University of Glasgow
Mechanisms of immunotherapy resistance in hepatocellular carcinoma
Abstract
dc:description.abstractHepatocellular Carcinoma is the 7th most common cause of cancer and 2nd highest cause of cancer mortality worldwide. For patients who present with early stage disease, cure can be achieved by surgical resection or liver transplantation. The majority of patients, however, present with late stage disease where palliative therapies are the only treatment option. Immunotherapy is an emerging and promising treatment option for patients with advanced HCC. It allows a cytotoxic response to be directed against tumours and in some cases, can provide complete and durable disease control. However, not all patients will respond to immune checkpoint inhibition. Evidence suggests this is likely due to tumour intrinsic molecular processes that induce primary or secondary resistance to immunotherapy. Therefore, there is an urgent need to identify new strategies to increase the efficacy of immunotherapy for all patients. Here, I show the development of genetically engineered mouse models which recapitulate key aspects of the human HCC tumour microenvironment. Using a range of techniques including immunohistochemistry and sequencing, I demonstrate response to immunotherapy in these models is associated with the presence of immune cells and go on to identify potential mechanisms responsible for immunotherapy resistance. This work will underpin the basis for testing new treatments in relevant model systems, with the overall objective of improving patient care through translation of new therapies which improve responses to immunotherapy.
Degree
thesis:*- Level dc:type.qualificationlevel
- PhD
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Drake, Thomas M.
Subjects
dc:subject × 1Rights
- Language dc:language
- en
Identifiers
dc:identifier.*- DOI dc:identifier.doi
- https://doi.org/10.5525/gla.thesis.84000